John E. Skonier
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 4
- Oncology top 5%
- Bone health and treatments 3
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 4
- TGF-β signaling in diseases 3
- Bone Metabolism and Diseases 3
- Receptor Mechanisms and Signaling 2
- Cancer Research top 10%
-
- Immune Cell Function and Interaction 4
-
- Virus-based gene therapy research 2
John E. Skonier
15 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Orthopedics and Sports Medicine 376
- Immunology and Allergy 224
- Oncology 607
- Molecular Biology 1.4k
- Cancer Research 248
Countries citing papers authored by John E. Skonier
This map shows the geographic impact of John E. Skonier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Skonier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Skonier more than expected).
Fields of papers citing papers by John E. Skonier
This network shows the impact of papers produced by John E. Skonier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Skonier. The network helps show where John E. Skonier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John E. Skonier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 82 | |
| 2 | 2004 | 180 | |
| 3 | 2004 | 139 | |
| 4 | Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Proteinbreakdown → | 2001 | 751 |
| 5 | 1997 | 7 | |
| 6 | 1997 | 13 | |
| 7 | 1997 | 34 | |
| 8 | 1996 | 12 | |
| 9 | 1996 | 15 | |
| 10 | 1995 | 194 | |
| 11 | 1995 | 66 | |
| 12 | 1994 | 245 | |
| 13 | 1992 | 465 | |
| 14 | 1992 | 23 | |
| 15 | Development of a vector system for the expression of bioengineered proteins. | 1989 | 1 |
About John E. Skonier
John E. Skonier is a scholar working on Immunology and Allergy, Immunology, Molecular Biology, Oncology and Neurology, having authored 15 papers that have together received 2.2k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (4 papers), Cell Adhesion Molecules Research (4 papers), Immune Cell Function and Interaction (4 papers), Bone health and treatments (3 papers), TGF-β signaling in diseases (3 papers), Bone Metabolism and Diseases (3 papers), Virus-based gene therapy research (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (376 citations), Immunology and Allergy (224 citations), Oncology (607 citations), Molecular Biology (1.4k citations) and Cancer Research (248 citations). John E. Skonier has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include A F Purchio, Gregory D. Plowman, Kelly L. Bennett, Linda Madisen, James C. Geoghegan, Changpu Yu, David G. Winkler, John Latham, Sean Proll and Mary E. Brunkow. Their work appears in journals such as Biochemistry, Journal of Biological Chemistry, DNA and Cell Biology, Growth Factors and Protein Engineering Design and Selection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.